Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
155.4 USD | -0.40% | +0.61% | +0.04% |
Apr. 22 | Celanese Corporation Announces Directorate Changes | CI |
Apr. 19 | RBC Raises Price Target on Celanese to $171 From $165, Keeps Outperform Rating | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.04% | 17.41B | B+ | ||
+11.31% | 62.8B | A- | ||
-5.19% | 45.4B | A- | ||
+15.01% | 40.32B | B+ | ||
+20.63% | 25.83B | A- | ||
+5.07% | 18.21B | C+ | ||
+4.48% | 15.64B | B+ | ||
-17.27% | 15.51B | A- | ||
-20.22% | 13.42B | C+ | ||
-28.15% | 12.79B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CE Stock
- Ratings Celanese Corporation